Skip to main content

Saliva haloperidol concentrations in schizophrenic patients: relation to serum haloperidol and prolactin concentrations

  • Chapter
Clinical Pharmacology in Psychiatry

Abstract

Measurement of drugs in saliva has been proposed as a non-invasive means by which serum drug concentrations can be assessed (Horning et al., 1977). The concentrations of many drugs in saliva are equal to or less than the concentrations of free (non-protein-bound) drug in plasma or serum (Horning et al., 1977; Stephen et al., 1980). However, recent studies have shown that neuroleptics such as chlorpromazine (May et al., 1981) and haloperidol (Yamazumi and Miura, 1981) are present in saliva in concentrations exceeding the total plasma concentration of drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Cooper, T.B., Bark, N. and Simpson, G.M. (1981). Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure. Psychopharmacology, 74, 115–21

    Article  CAS  PubMed  Google Scholar 

  • Forsman, A. and Ohman, R. (1977). Studies on serum protein binding of haloperidol. Curr. Ther. Res., 21, 245–55

    CAS  PubMed  Google Scholar 

  • Forsman, A. and Ohman, R. (1979). Interindividual variation of clinical response to haloperidol. In Biological Psychiatry Today (ed. J. Obiols, C. Ballus, E. Gonzalez Monclus and J. Pujol), Elsevier/North-Holland, Amsterdam, pp. 949–54

    Google Scholar 

  • Hays, S.E., Poland, R.E. and Rubin, R.T. (1980). Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies. J. Pharmacol. Exp. Ther., 214, 362–7

    CAS  PubMed  Google Scholar 

  • Horning, M.G., Brown, L., Nowlin, J., Lertratanangkoon, K., Kellaway, P. and Zion, T.E. (1977). Use of saliva in therapeutic drug monitoring. Clin. Chem., 23, 157–64

    CAS  PubMed  Google Scholar 

  • Jacobs, K.W. (1976). A table for the determination of experiment-wise error rate (alpha) from independent observations. Ed. Psychol. Measur., 36, 899–903

    Article  Google Scholar 

  • May, P.R.A., Van Putten, T., Jenden, D.J., Yale, C. and Dixon, W.J. (1981). Chlorpromazine levels and the outcome of treatment in schizophrenic patients. Arch. Gen. Psychiatry, 38, 202–7

    Article  CAS  PubMed  Google Scholar 

  • Poland, R.E. and Rubin, R.T. (1981). Radioimmunoassay of haloperidol in human serum: correlation of serum haloperidol with serum prolactin. Life Sci., 29, 1837–45

    Article  CAS  PubMed  Google Scholar 

  • Poland, R.E. and Rubin, R.T. (1982). Saliva cortisol levels following dexamethasone administration in endogenously depressed patients. Life Sci., 30, 177–81

    Article  CAS  PubMed  Google Scholar 

  • Rubin, R.T., Forsman, A., Heykants, J., Ohman, R., Tower, B. and Michiels, M. (1980). Serum haloperidol determinations in psychiatric patients. Arch. Gen. Psychiatry, 37, 1069–74

    Article  CAS  PubMed  Google Scholar 

  • Rubin, R.T. and Hays, S.E. (1980). The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psychoneuroendocrinology, 5, 121–37

    Article  CAS  PubMed  Google Scholar 

  • Rubin, R.T. and Poland, R.E. (1981). Serum haloperidol determinations and their contribution to the treatment of schizo-phrenia. In Clinical Pharmacology in Psychiatry; Neuroleptic and Antidepressant Research (ed. E. Usdin, S.G. Dahl, L.F. Gram and O. Lingjaerde), Macmillan, London, pp. 217–25

    Google Scholar 

  • Stephen, K.W., McCrossan, J., Mackenzie, D., Macfarlane, C.B. and Speirs, C.F. (1980). Factors determining the passage of drugs from blood into saliva. Br. J. Clin. Pharmacol., 9, 51–5

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yamazumi, S. and Miura, S. (1981). Haloperidol concentrations in saliva and serum: determination by the radioimmunoassay method. Int. Pharmacopsychiat., 16, 174–83

    CAS  Google Scholar 

  • Zivin, J.A. and Bartko, J.J. (1976). Statistics for disinterested scientists. Life Sci., 18, 15–26

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1983 The contributors

About this chapter

Cite this chapter

Poland, R.E., Rubin, R.T., Friedmann, C.T.H., Kaston, B. (1983). Saliva haloperidol concentrations in schizophrenic patients: relation to serum haloperidol and prolactin concentrations. In: Gram, L.F., Usdin, E., Dahl, S.G., Kragh-Sørensen, P., Sjöqvist, F., Morselli, P.L. (eds) Clinical Pharmacology in Psychiatry. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06671-1_17

Download citation

Publish with us

Policies and ethics